Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07JVO
|
|||
Former ID |
DNCL002688
|
|||
Drug Name |
Fosbretabulin
|
|||
Synonyms |
Zybrestat (TN)
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Rheumatoid arthritis [ICD-11: FA20] | Phase 2 | [1] | |
Company |
OXiGENE South
|
|||
Structure |
Download2D MOL |
|||
Formula |
C18H21O8P
|
|||
Canonical SMILES |
COC1=C(C=C(C=C1)C=CC2=CC(=C(C(=C2)OC)OC)OC)OP(=O)(O)O
|
|||
InChI |
1S/C18H21O8P/c1-22-14-8-7-12(9-15(14)26-27(19,20)21)5-6-13-10-16(23-2)18(25-4)17(11-13)24-3/h5-11H,1-4H3,(H2,19,20,21)/b6-5-
|
|||
InChIKey |
WDOGQTQEKVLZIJ-WAYWQWQTSA-N
|
|||
CAS Number |
CAS 222030-63-9
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT02279602) Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.